Patents by Inventor Jorg Eibl

Jorg Eibl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160031781
    Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.
    Type: Application
    Filed: August 3, 2015
    Publication date: February 4, 2016
    Applicant: Genzyme Corporation
    Inventors: Hans-Jorg EIBL, Peter Hoffman
  • Patent number: 8497388
    Abstract: Phospholipid-analogous compounds of the general formula (I) in which a is b is where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of froth 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: July 30, 2013
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften. e.V.
    Inventor: Hans-Jörg Eibl
  • Publication number: 20120172631
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)
    Type: Application
    Filed: December 13, 2011
    Publication date: July 5, 2012
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. V.
    Inventor: Hans-Jõrg EIBL
  • Publication number: 20120064147
    Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.
    Type: Application
    Filed: April 19, 2011
    Publication date: March 15, 2012
    Applicants: Genzyme Corporation, Max-Planck Gesellschaft Zur Foerderung Der Wissenshaften E.V.
    Inventors: Hans-Jorg EIBL, Peter Hoffmann
  • Publication number: 20120009246
    Abstract: Phospholipid-analogous compounds of the general formula (I) in which a is b is where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of froth 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.
    Type: Application
    Filed: April 12, 2011
    Publication date: January 12, 2012
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventor: Hans-Jörg EIBL
  • Patent number: 8076520
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: December 13, 2011
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventor: Hans-Jörg Eibl
  • Patent number: 7939683
    Abstract: Phospholipid-analogous compounds of the general formula (I) in which A is where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 carbon atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3— a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 carbon atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2, and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1, z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: May 10, 2011
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventor: Hans-Jörg Eibl
  • Publication number: 20100280282
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)
    Type: Application
    Filed: March 31, 2010
    Publication date: November 4, 2010
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventor: Hans-Jörg EIBL
  • Publication number: 20100183705
    Abstract: Phospholipid-analogous compounds of the general formula (I) in which A where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to S? or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.
    Type: Application
    Filed: September 28, 2009
    Publication date: July 22, 2010
    Applicant: Max-Planck-Gesellschaft zur Förderung du Wissenschaften e.V.
    Inventor: Hans-Jörg EIBL
  • Patent number: 7709464
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: May 4, 2010
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. V.
    Inventor: Hans-Jorg Eibl
  • Patent number: 7595411
    Abstract: The present invention relates to compositions comprising a water-insoluble pharmaceutically active ingredient or a substance having low water solubility, and a compound represented by Structural Formula (I): in which A is: The present invention further relates to methods of solubilizing substances of low water solubility, and methods of preparing compositions suitable for intravenous administration.
    Type: Grant
    Filed: October 21, 2004
    Date of Patent: September 29, 2009
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventor: Hans-Jörg Eibl
  • Publication number: 20090035358
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)
    Type: Application
    Filed: March 31, 2008
    Publication date: February 5, 2009
    Applicant: Max-Planck-Gesselschaft zur Forderung Der Wissenschaften E.V.
    Inventor: Hans-Jorg Eibl
  • Publication number: 20080090781
    Abstract: The invention relates to novel medicament formulations containing, as active ingredients, alkylphosphocholines and the like, alkyl-alkanediol-phosphocholines and the like, and (ether)lysolecithines and the like, in different forms of embodiment. Said active ingredients are integral constituents of liposomes, also containing cholesterol and the like and a negative charge carrier. The medicament formulations are especially suitable for the treatment and/or prophylaxis of cancer, protozoan diseases such as leishmaniasis and amoebic diseases, acariasis and diseases caused by arthropods, and bacterial diseases, such as ehrlichiosis. Ocular diseases accompanied by uncontrolled cellular processes can also be advantageously influenced.
    Type: Application
    Filed: October 19, 2005
    Publication date: April 17, 2008
    Applicant: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V.
    Inventors: Hans jörg Eibl, Susanne Christine Wieland-Berghausen, Jean Steffan
  • Patent number: 7351428
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined formula (A)
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: April 1, 2008
    Assignee: Max-Planck-Gesselschaft zur Forderung der Wissenschaften E.V.
    Inventor: Hans-Jörg Eibl
  • Publication number: 20050165245
    Abstract: The present invention relates to compositions comprising a water-insoluble pharmaceutically active ingredient or a substance having low water solubility, and a compound represented by Structural Formula (I): in which A is: The present invention further relates to methods of solubilizing substances of low water solubility, and methods of preparing compositions suitable for intravenous administration.
    Type: Application
    Filed: October 21, 2004
    Publication date: July 28, 2005
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventor: Hans-Jorg Eibl
  • Publication number: 20040247659
    Abstract: The present invention concerns new liposome preparations which contain (ester)-lysolecithin compounds. The liposomes are especially suitable for packaging active substances.
    Type: Application
    Filed: March 29, 2004
    Publication date: December 9, 2004
    Inventor: Jorg Eibl
  • Patent number: 6828453
    Abstract: Phospholipid-analogous compounds of the general formula (I) in which A where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b 5 can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n≠2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y 10 is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: December 7, 2004
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V
    Inventor: Hans-Jörg Eibl
  • Publication number: 20040213836
    Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined formula (A) 1
    Type: Application
    Filed: May 7, 2004
    Publication date: October 28, 2004
    Applicant: Max-Planck-Gesselschaft zur Forderung Der Wissenschaften E.V.
    Inventor: Hans-Jorg Eibl
  • Publication number: 20030198663
    Abstract: Phospholipid-analogous compounds of the general formula (I) 1
    Type: Application
    Filed: March 4, 2003
    Publication date: October 23, 2003
    Inventor: Hans-Jorg Eibl
  • Patent number: 6545169
    Abstract: Phospholipid-analogous compounds of the general formula (I) in which A where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is>0 or c can be alkyl with 1 to 3 carbon atoms when n≠2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: April 8, 2003
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventor: Hans-Jörg Eibl